news First cancer-promoting oncogenes discovered in choroid plexus carcinoma 21 May 2015 | By Victoria White Researchers have identified three genes that play a pivotal role in choroid plexus carcinoma, a discovery that could lead to more effective treatment...
news Broad Institute receives $10 million from the Gerstner Family Foundation to research cancer drug resistance 18 May 2015 | By Victoria White Broad Institute of MIT and Harvard are to receive a $10 million gift from the Gerstner Family Foundation that will expand cancer research...
news Contraceptive and cholesterol-lowering drug combination (BaP) used to treat cancer 15 May 2015 | By Victoria White The BaP combination of a cholesterol-lowering drug, bezafibrate and a contraceptive steroid could be an effective treatment for a range of cancers.
news Invectys initiates Phase I clinical trial evaluating INVAC-1 therapeutic vaccine for cancer patients 13 May 2015 | By Victoria White A Phase I clinical trial of INVAC-1, an innovative therapeutic DNA vaccine, which specifically targets the telomerase enzyme (hTERT), has commenced...
news Significant progress made towards individualised cancer immunotherapy 12 May 2015 | By Victoria White Mainz-based researchers have made significant advances with regard to the development of individualised cancer immunotherapy strategies...
news BioNTech and Lilly enter into cancer immunotherapy research collaboration 12 May 2015 | By Victoria White BioNTech and Lilly are to collaborate to identify and validate novel tumour targets and their corresponding TCRs in one or more types of cancer...
news Studies confirm TRXE-009 kills resistant paediatric brain cancer cells 11 May 2015 | By Victoria White Novogen, in conjunction with Australian paediatric cancer researchers, released key preclinical data on experimental cancer drug-candidate, TRXE-009...
news New anti-cancer stem cell compound in development 7 May 2015 | By Victoria White Cardiff University scientists have developed a novel anti-cancer stem cell agent capable of targeting aggressive tumour forming cells...
news ROCK inhibitors could stop the spread of melanoma cells 6 May 2015 | By Victoria White Scientists at The Institute of Cancer Research have found that ROCK inhibitors dramatically reduced the ability of melanoma cells to move through tissue...
news ME-344 shows enhanced anti-tumour activity in combination with tyrosine-kinase inhibitor in preclinical studies 6 May 2015 | By Victoria White MEI Pharma has announced new preclinical data showing mitochondria-specific effects of the Company's investigational drug candidate ME-344 in cancer cells...
news Breast cancer vaccines may work better with silicon microparticles 5 May 2015 | By Victoria White The effectiveness of cancer vaccines could be dramatically boosted by first loading the cancer antigens into silicon microparticles...
news NIH to fund $10.5 million multi-site, interdisciplinary research effort to investigate the role of non-inherited genetic mutations in schizophrenia 30 April 2015 | By Victoria White NIH funded project to identify the causes of schizophrenia and other neurodevelopmental disorders to guide development of more effective treatments...
news New therapeutic target for colorectal cancer has been identified 28 April 2015 | By Victoria White Researchers at the Institut Hospital del Mar d’Investigacions Mèdiques (IMIM) have identified a new way of treating colorectal cancer...
news New signalling pathway discovered in HER2-positive breast cancer 28 April 2015 | By Victoria White A team at CSHL has published results of experiments that lay bare a previously unknown pathway activated in HER2-positive breast cancer...
news arGEN-X announces publication on therapeutic potential of ARGX-115 in cancer immunotherapy 24 April 2015 | By Victoria White arGEN-X and de Duve Institute/UCL/WELBIO have announced the publication of new data showing that ARGX-115 blocks the activity of GARP...
